Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $9,866.00 |
|---|---|
| Enterprise Value | $62.92 Million |
| Earnings per Share | $-0.32 |
| Beta | 0.81 |
| Outstanding Shares | 98,675,427 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 1.18 |
| Enterprise Value to EBIT | -3.38 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 1.11 |
| Debt to Equity | -1.11 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Valeo Pharma Inc. is a Canadian specialty pharmaceutical firm dedicated to sourcing, licensing, and selling a variety of medicinal products, with a primary emphasis on respiratory, specialized, and hospital-grade generic drugs. Its exten...